NBD AI Bulletin -- Amoy Diagnostics Co., Ltd. (the Company, SZ 300685, closing price: 77.29 yuan) announced on July 13 that Mr. Zhou Wengang, deputy general manager of the Company, offered to resign from his position for personal reasons. After the resignation, Zhou Wengang will no longer hold any position in the Company and its subsidiaries.

As of the date of this announcement, Zhou Wengang holds approximately 110,000 of the Company's shares, of which 90,000 are incentive stocks that are still within the lock-up period.

According to the 2019 annual report, Amoy Diagnostics Co., Ltd. mainly engages in in-vitro diagnostics, accounting for 100.0% of its revenue.

Amoy Diagnostics Co., Ltd.'s general manager and chairman is Zheng Limou, male, 67 years old, U.S. national, Ph.D.

(By Tan Yuhan)

Disclaimer: This article is for informational purposes only and does Not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.